Trial
NCT05554627
VA Aripiprazole vs Esketamine for Treatment Resistant Depression
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
VA Office of Research and Development
Collaborators
—
Condition
Depressive Disorder, Major
Intervention
Esketamine
Why stopped
Study funding was withdrawn by study sponsor (CSR\&D) prior to enrollment due to budget constraints.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-05